September 14, 2018

EUROPEAN MEDICINES AGENCY VALIDATES MARKETING AUTHORIZATION APPLICATION FOR TROGARZOTM

Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that the European Medicines Agency (“EMA”) has confirmed the validity of the marketing authorization application for TrogarzoTM (ibalizumab) filed on August 28, 2018.